|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"wei jcc"
Showing items 1-25 of 204 (9 Page(s) Totally)
1 2 3 4 5 6 7 8 9 > >>
View [10|25|50] records per page
| 國家衛生研究院 |
2025-08 |
Comparative outcomes of adding SGLT2 inhibitors versus incretin-based therapies to insulin in type 2 diabetes
|
Yen, FS;Wei, JCC;Huang, YH;Li, PY;Tsai, FJ;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2025-08 |
Impact of SGLT2 inhibitors on kidney health and survival in patients with polycystic kidney disease and type 2 diabetes
|
Yen, FS;Huang, JY;Dong, C;Hwu, CM;Hsu, CC;Wei, JCC |
| 國家衛生研究院 |
2025-07-22 |
Sodium-glucose cotransporter 2 inhibitors use in patients with liver cirrhosis
|
Yen, FS;Hou, MC;Wei, JCC;Huang, YH;Shih, YH;Pan, CW;Wang, ST;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-06-02 |
Association of DPP-4 inhibitors with respiratory and cardiovascular complications in patients with COPD: A nationwide cohort study
|
Yen, FS;Wei, JCC;Ko, FS;Huang, YH;Yip, HT;Tsai, FJ;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-06 |
SGLT-2 inhibitors and the risk of chronic obstructive pulmonary disease exacerbations and mortality in chronic obstructive pulmonary disease patients
|
Yen, FS;Wei, JCC;Huang, YH;Hsu, TJ;Wang, ST;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-05-23 |
Microvascular complications and cancer risk in type 2 diabetes: A population-based study
|
Yen, YH;Wei, JCC;Yen, FS;Kao, YS;Lin, HJ;Cho, DY;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-05 |
Sodium-glucose cotransporter2 inhibitors and associated liver-related outcomes in diabetes patients
|
Yen, FS;Wei, JCC;Wang, C;Hou, MC;Yu, TS;Huang, YH;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2025-02-25 |
Effects of SGLT2 inhibitors on transplant survival and key clinical outcomes in heart transplant recipients with diabetes
|
Yen, FS;Hung, YM;Huang, JY;Hsu, CC;Cheng, WY;Hwu, CM;Wei, JCC |
| 國家衛生研究院 |
2025-02 |
The impact of pay-for-performance care on the mortality and cardiovascular outcomes in older adults with newly diagnosed type 2 diabetes: a nationwide population-based cohort study
|
Yen, FS;Wei, JCC;Lin, SY;Hsu, J;Yeh, YK;Huang, YH;Hsu, TJ;Cho, DY;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2024-11-14 |
Impact of family income on the development of gestational diabetes mellitus and the associated birth outcomes: A nationwide study
|
Yen, FS;Wei, JCC;Wu, YL;Lo, YR;Chen, CM;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2024-1016 |
Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD
|
Yen, FS;Hsu, CC;Wei, JCC;Tsai, FJ;Huang, YH;Yu, TS;Hwu, CM |
| 國家衛生研究院 |
2024-08-29 |
Microvascular disease and its association with dementia in patients with type 2 diabetes: A nationwide cohort study in Taiwan
|
Yen, YH;Yen, FS;Ko, FS;Wei, JCC;Huang, YH;Yu, TS;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2024-06-12 |
Sodium-glucose cotransporter-2 inhibitors and nephritis among patients with systemic lupus erythematosus
|
Yen, FS;Wang, SI;Hsu, CC;Hwu, CM;Wei, JCC |
| 國家衛生研究院 |
2024-01-04 |
Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes
|
Yen, FS;Hou, MC;Wei, JCC;Shih, YH;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2023-12-20 |
Sodium-glucose cotransporter 2 inhibitors and risk of retinopathy in patients with type 2 diabetes
|
Yen, FS;Wei, JCC;Yu, TS;Hung, YT;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-11-30 |
Parental income level and risk of developing type 2 diabetes in youth
|
Yen, FS;Wei, JCC;Liu, JS;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2023-08-09 |
Additive effect of frailty with distinct multimorbidity patterns on mortality amongst middle-aged and older adults in Taiwan: A 16-year population-based study
|
Chu, WM;Ho, HE;Yeh, CJ;Wei, JCC;Arai, H;Lee, MC |
| 國家衛生研究院 |
2023-07-21 |
COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs
|
Tsai, JJ;Liu, LT;Chen, CH;Chen, LJ;Wang, SI;Wei, JCC |
| 國家衛生研究院 |
2023-05-09 |
Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study
|
Yen, FS;Wei, JCC;Shih, YH;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2023-02-17 |
Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes
|
Yen, FS;Wei, JCC;Hung, YT;Hsu, CY;Hwu, CM;Hsu, CC |
| 國家衛生研究院 |
2023-01 |
Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetes
|
Yen, FS;Wei, JCC;Yip, HT;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-12-21 |
Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis
|
Yen, FS;Hou, MC;Wei, JCC;Shih, YH;Hsu, CY;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-11-15 |
Sulfonylurea use in patients with type 2 diabetes and COPD: A nationwide population-based cohort study
|
Yen, FS;Wei, JCC;Yu, TS;Hsu, CY;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-11 |
Long-term outcomes of the pay-for-performance program for patients with young-onset (20–40 years of age) type 2 diabetes
|
Yen, FS;Wei, JCC;Hung, YT;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2022-08-22 |
Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
|
Yen, FS;Wei, JCC;Chiu, LT;Hsu, CC;Hwu, CM |
Showing items 1-25 of 204 (9 Page(s) Totally)
1 2 3 4 5 6 7 8 9 > >>
View [10|25|50] records per page
|
